Document Detail

Pharmacologic Therapy for New York Heart Association Class IV Heart Failure.
MedLine Citation:
PMID:  21906245     Owner:  NLM     Status:  In-Data-Review    
Congest Heart Fail. 2011;17:213-219. © 2011 Wiley Periodicals, Inc. As the incidence of heart failure increases, the number of patients with advanced heart failure is anticipated to grow. Substantial progress in the treatment of heart failure has been achieved over the past few decades. Several classes of medications have been studied and found effective, including beta-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, aldosterone antagonists, vasodilators, digoxin, and inotropes. The evidence base for the use of these medications in the treatment of patients with New York Heart Association (NYHA) class IV heart failure is reviewed.
Marco A Caccamo; Peter M Eckman
Related Documents :
16227145 - A statin in the treatment of heart failure? controlled rosuvastatin multinational study...
12866665 - Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. search ...
12858125 - Treatment of hypertension for patients with diastolic dysfunction.
14656255 - New and emerging drug therapies for the management of acute heart failure.
25476195 - Status of primary prevention of sudden cardiac death with implantable cardioverter defi...
22696335 - Anticoagulation versus placebo for heart failure in sinus rhythm.
Publication Detail:
Type:  Journal Article     Date:  2011-07-21
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  17     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  213-9     Citation Subset:  IM    
Copyright Information:
© 2011 Wiley Periodicals, Inc.
From the Division of Cardiovascular Disease, Department of Cardiology, University of Minnesota Medical Center, Minneapolis, MN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multivariate risk scores and patient outcomes in advanced heart failure.
Next Document:  Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring...